Monday, April 27, 2026
HomeTagsGenerate:Biomedicines

Tag: Generate:Biomedicines

Healthcare

Generate:Biomedicines & Novartis Collaborate on AI Proteins

Generate:Biomedicines announced a multi-target collaboration with Novartis to discover and develop protein therapeutics across multiple disease areas. The collaboration leverages Generate’s proprietary generative AI...
Healthcare

Generate:Biomedicines and Roswell Park Comprehensive Cancer Center Enter into a Collaboration Agreement to Accelerate Novel Cell Therapies for Oncology Using Generative AI

Multi-year collaboration will enable development of complex, cutting-edge cell therapies and armoring technologies for solid tumor targets Generate:Biomedicines and Roswell Park Comprehensive Cancer Center announced...
Life Sciences

Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics

Generate:Biomedicines, a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform, announced that it has raised $273 million in Series C financing. This financing...

Recent Published

About Us

Discover the future of artificial intelligence at AITech365. Explore the latest AI news, delve into insightful interviews with industry experts, and stay informed about the most exciting and trending topics shaping the world of AI.

Latest

Popular

Quick Link

© 2026 AITech365. All Rights Reserved. Website Undertaking: Data Demand